APA (7th ed.) Citation

BA, R., A, C., M, G., OM, N., N, N., JE, M., . . . DG, P. (2026). Safety, Tolerability, and Pharmacokinetics of 6-Diazo-5-Oxo-L-Norleucine in Malawian Adults With and Without Malaria: A Phase 1 Dose-Escalation Clinical Trial. The Journal of infectious diseases, 233(5), e1226. https://doi.org/10.1093/infdis/jiag121

Chicago Style (17th ed.) Citation

BA, Riggle, et al. "Safety, Tolerability, and Pharmacokinetics of 6-Diazo-5-Oxo-L-Norleucine in Malawian Adults With and Without Malaria: A Phase 1 Dose-Escalation Clinical Trial." The Journal of Infectious Diseases 233, no. 5 (2026): e1226. https://doi.org/10.1093/infdis/jiag121.

MLA (9th ed.) Citation

BA, Riggle, et al. "Safety, Tolerability, and Pharmacokinetics of 6-Diazo-5-Oxo-L-Norleucine in Malawian Adults With and Without Malaria: A Phase 1 Dose-Escalation Clinical Trial." The Journal of Infectious Diseases, vol. 233, no. 5, 2026, p. e1226, https://doi.org/10.1093/infdis/jiag121.